- Home
- Knowledge Base
- References
References
Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentation and chronic drug treatment.
Rossner S, Wortwein G, Gu Z, Yu J, Schliebs R, Bigl V, Perez-Polo JR (1997) Cholinergic control of nerve growth factor in adult rats: evidence from cortical cholinergic deafferentation and chronic drug treatment. J Neurochem 69:947-953. doi: 10.1046/j.1471-4159.1997.69030947.x
Related Products: 192-IgG-SAP (Cat. #IT-01)
Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat.
Baskerville KA, Schweitzer JB, Herron P (1997) Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience 80:1159-1169. doi: 10.1016/s0306-4522(97)00064-x
Related Products: 192-IgG-SAP (Cat. #IT-01)
Basal forebrain cholinergic immunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations of alpha(2)- and beta-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals.
Heider M, Schliebs R, Rossner S, Bigl V (1997) Basal forebrain cholinergic immunolesion by 192IgG-saporin: evidence for a presynaptic location of subpopulations of alpha(2)- and beta-adrenergic as well as 5-HT2A receptors on cortical cholinergic terminals. Neurochem Res 22:957-966. doi: 10.1023/a:1022418708293
Related Products: 192-IgG-SAP (Cat. #IT-01)
Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves’ disease: a comparison with those present in type1 diabetes.
Tremble J, Morgenthaler NG, Vlug A, Powers AC, Christie MR, Scherbaum WA, Banga JP (1997) Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves’ disease: a comparison with those present in type1 diabetes. J Clin Endocrinol Metab 82(8):2664-2670. doi: 10.1210/jcem.82.8.4171 PMID: 9253351
Related Products: GAD65 (B78) Human Monoclonal (Cat. #AB-N12), GAD65 (B96) Human Monoclonal (Cat. #AB-N13)
Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin.
Wiley RG, Lappi DA (1997) Destruction of neurokinin-1 receptor expressing cells in vitro and in vivo using substance P-saporin. Neurosci Lett 230:97-100. doi: 10.1016/s0304-3940(97)00490-4
Related Products: SP-SAP (Cat. #IT-07)
Cholinergic deafferentation exacerbates seizure-induced loss of somatostatin-immunoreactive neurons in the rat hippocampus.
Jolkkonen J, Kahkonen K, Pitkanen A (1997) Cholinergic deafferentation exacerbates seizure-induced loss of somatostatin-immunoreactive neurons in the rat hippocampus. Neuroscience 80:401-411. doi: 10.1016/s0306-4522(96)00650-1
Related Products: 192-IgG-SAP (Cat. #IT-01)
Effects of cholinergic denervation on seizure development and neurotrophin messenger RNA regulation in rapid hippocampal kindling.
Ferencz I, Kokaia M, Keep M, Elmer E, Metsis M, Kokaia Z, Lindvall O (1997) Effects of cholinergic denervation on seizure development and neurotrophin messenger RNA regulation in rapid hippocampal kindling. Neuroscience 80:389-399. doi: 10.1016/s0306-4522(97)00006-7
Related Products: 192-IgG-SAP (Cat. #IT-01)
Potentiation of glutaminergic EPSPs in rat CA1 hippocampal neurons after selective cholinergic denervation by 192 IgG-saporin.
Jovenceau A, Billard JM, Lamour Y, Dutar P (1997) Potentiation of glutaminergic EPSPs in rat CA1 hippocampal neurons after selective cholinergic denervation by 192 IgG-saporin. Synapse 26:292-300. doi: 10.1002/(SICI)1098-2396(199707)26:3<292::AID-SYN10>3.0.CO;2-Y
Related Products: 192-IgG-SAP (Cat. #IT-01)
Selective immunolesions of hippocampal cholinergic input fail to impair spatial working memory.
McMahan RW, Sobel TJ, Baxter MG (1997) Selective immunolesions of hippocampal cholinergic input fail to impair spatial working memory. Hippocampus 7:130-136. doi: 10.1002/(SICI)1098-1063(1997)7:2<130::AID-HIPO2>3.0.CO;2-R
Related Products: 192-IgG-SAP (Cat. #IT-01)
Expression of blood-brain barrier characteristics following neuronal loss and astroglial damage after administration of anti-Thy-1 immunotoxin.
Krum JM, Kenyon KL, Rosenstein JM (1997) Expression of blood-brain barrier characteristics following neuronal loss and astroglial damage after administration of anti-Thy-1 immunotoxin. Exp Neurol 146:33-45. doi: 10.1006/exnr.1997.6528
Related Products: OX7-SAP (Cat. #IT-02)
